Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team

You seem to be using a wider screen, would you like to enable a wider viewing experience on this page?

Life Science Companies as Investments | Life Science Night Dec. 2, 2024

By Inderes

Antti Siltanen, Life Science Analyst, PhD, talks about life science companies as investments.

Life Science Night
Keynote – Antti Siltanen, Inderes (link)
Aiforia – Jukka Tapaninen, CEO (link)
Herantis Pharma – Antti Vuolanto, CEO (link)
Faron Pharmaceuticals – Juho Jalkanen, CEO (link)

Life Science Night December 2, 2024 (link)
Health Technology & Pharmaceutical Developer Night December 11, 2023 (link)
Health Technology & Pharmaceutical Developer Night December 13, 2022 (link)

Stay up to date
Aiforia Technologies
BBS-Bioactive Bone Substitutes
Bioretec
Biohit
Faron Pharmaceuticals
Modulight
Nexstim
Orion
Bittium
Detection Technology
Optomed
Revenio Group
Nightingale Health
Herantis Pharma
Nanoform Finland
Investor events

Recent videos

UPM and Sappi are planning a joint venture in graphic papers
2025-12-04 13:00 UPM-Kymmene
GreenMobility: How far away are driverless cars in Denmark
2025-12-04 11:32 GreenMobility
Systemair, Audiocast, Q2'25/26
2025-12-04 09:00 Systemair
Hafnia – Presentation of the quarterly report for Q3 2025
2025-12-02 11:00 Hafnia
Admicom Capital Markets Day 2025
2025-12-02 09:00 Admicom
View all videos
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.